Treatment | Age group (years) | ||||||
---|---|---|---|---|---|---|---|
45–64 | 65–74 | 75–84 | >85 | <75 | ⩾75 | All ages | |
Number | 120 | 248 | 391 | 240 | 377 | 631 | 1008 |
Furosemide | 66 | 146 | 238 | 146 | 216 | 384 | 600 |
(55.0%) | (58.9%) | (60.9%) | (60.8%) | (57.3%) | (60.9%) | (59.5%) | |
Any diuretic | 89 | 200 | 329 | 190 | 293 | 519 | 812 |
(74.2%) | (80.7%) | (84.1%) | (79.2%) | (77.7%) | (82.3%) | (80.6%) | |
ACE inhibitor | 63 | 124 | 145 | 62 | 188 | 207 | 395 |
(52.5%) | (50.0%) | (37.1%) | (25.8%) | (49.9%) | (32.8%) | (39.2%) | |
ARB | 9 | 10 | 22 | 7 | 19 | 29 | 48 |
(7.5%) | (4.0%) | (5.6%) | (2.9%) | (5.0%) | (4.6%) | (4.8%) | |
β Blocker | 34 | 61 | 84 | 36 | 96 | 120 | 216 |
(28.3%) | (24.6%) | (21.5%) | (15.0%) | (25.5%) | (19.0%) | (21.4%) | |
Spironolactone | 15 | 26 | 29 | 16 | 41 | 45 | 86 |
(12.5%) | (10.5%) | (7.4%) | (6.9%) | (10.9%) | (7.1%) | (8.5%) | |
Digoxin | 23 | 48 | 86 | 50 | 72 | 136 | 208 |
(19.2%) | (19.4%) | (22.0%) | (20.8%) | (19.1%) | (21.6%) | (20.6%) | |
Any HF treatment | 106 | 216 | 355 | 200 | 328 | 555 | 883 |
(88.3%) | (87.1%) | (90.8%) | (83.3%) | (87.0%) | (87.9%) | (87.6%) |